D. Serin
BioMérieux
27 Papers
434 Citations
D. Serin is an academic researcher from BioMérieux. The author has contributed to research in topics: Medicine & Docetaxel. The author has an hindex of 9, co-authored 27 publications.
Chat about Author
Papers
Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial
Henri Roché,Pierre Fumoleau,Marc Spielmann,Jean-Luc Canon,Thierry Delozier,D. Serin,Michel Symann,Pierre Kerbrat,Patrick Soulié,Françoise Eichler,Patrice Viens,A. Monnier,A. Vindevoghel,Mario Campone,Marie-Josèphe Goudier,Jacques Bonneterre,Jean-Marc Ferrero,Anne-Laure Martin,Jean Genève,Bernard Asselain +19 more
TL;DR: The PACS 01 trial as mentioned in this paper compared six cycles of fluorouracil, epirubicin, and cyclophosphamide (FEC) with a sequential regimen of three cycles of FEC followed by three cycle of docetaxel as adjuvant treatment for node-positive early breast cancer.
601
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: The FNCLCC PACS 01 trial
Henri Roché,Pierre Fumoleau,Marc Spielmann,Jean-Luc Canon,Thierry Delozier,D. Serin,Michel Symann,Pierre Kerbrat,Patrick Soulié,Françoise Eichler,Patrice Viens,A. Monnier,A. Vindevoghel,Mario Campone,Marie-Josèphe Goudier,Jacques Bonneterre,Jean-Marc Ferrero,Anne-Laure Martin,Jean Genève,Bernard Asselain +19 more
- 01 Jan 2006
TL;DR: Sequential adjuvant chemotherapy with FEC followed by docetaxel significantly improves disease-free and overall survival in node-positive breast cancer patients and has a favorable safety profile.
377
Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study
Jean-Marc Extra,Eric C. Antoine,Anne Vincent-Salomon,Thierry Delozier,Pierre Kerbrat,Anne Bethune-Volters,Jean-Paul Guastalla,Marc Spielmann,Louis Mauriac,Jean-Louis Misset,D. Serin,Mario Campone,Christophe Hebert,Céline Remblier,Loïc Bergougnoux,Frank Campana,Moïse Namer +16 more
TL;DR: Results of the Hermine study examining the use of trastuzumab for metastatic breast cancer patients in routine practice, including patients who received trastzumab treatment beyond progression, are reported.
•Journal Article
Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases
J C Ferrandez,D. Serin,S Bouges +2 more
TL;DR: The retrospective study of 683 patients approaches the reality of lymphoedema of the upper limb after breast cancer treated with axillary clearance, where the real rate is not precise and the different factors which increase the risk are described.
42
•Journal Article
Lymphoscintigraphic aspects of the effects of manual lymphatic drainage
TL;DR: The visualization of the drainage routes in unexpected areas demonstrated the effectiveness of the technique in stimulating accessory routes useful for resorption of lymphedema.
34